Cargando…

mPEG-PLGA Nanoparticles Labelled with Loaded or Conjugated Rhodamine-B for Potential Nose-to-Brain Delivery

Nowdays, neurodegenerative diseases represent a great challenge from both the therapeutic and diagnostic points of view. Indeed, several physiological barriers of the body, including the blood brain barrier (BBB), nasal, dermal, and intestinal barriers, interpose between the development of new drugs...

Descripción completa

Detalles Bibliográficos
Autores principales: Craparo, Emanuela Fabiola, Musumeci, Teresa, Bonaccorso, Angela, Pellitteri, Rosalia, Romeo, Alessia, Naletova, Irina, Cucci, Lorena Maria, Cavallaro, Gennara, Satriano, Cristina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8471208/
https://www.ncbi.nlm.nih.gov/pubmed/34575584
http://dx.doi.org/10.3390/pharmaceutics13091508
_version_ 1784574404152262656
author Craparo, Emanuela Fabiola
Musumeci, Teresa
Bonaccorso, Angela
Pellitteri, Rosalia
Romeo, Alessia
Naletova, Irina
Cucci, Lorena Maria
Cavallaro, Gennara
Satriano, Cristina
author_facet Craparo, Emanuela Fabiola
Musumeci, Teresa
Bonaccorso, Angela
Pellitteri, Rosalia
Romeo, Alessia
Naletova, Irina
Cucci, Lorena Maria
Cavallaro, Gennara
Satriano, Cristina
author_sort Craparo, Emanuela Fabiola
collection PubMed
description Nowdays, neurodegenerative diseases represent a great challenge from both the therapeutic and diagnostic points of view. Indeed, several physiological barriers of the body, including the blood brain barrier (BBB), nasal, dermal, and intestinal barriers, interpose between the development of new drugs and their effective administration to reach the target organ or target cells at therapeutic concentrations. Currently, the nose-to-brain delivery with nanoformulations specifically designed for intranasal administration is a strategy widely investigated with the goal to reach the brain while bypassing the BBB. To produce nanosystems suitable to study both in vitro and/or in vivo cells trafficking for potential nose-to-brain delivery route, we prepared and characterized two types of fluorescent poly(ethylene glycol)-methyl-ether-block-poly(lactide-co-glycolide) (PLGA–PEG) nanoparticles (PNPs), i.e., Rhodamine B (RhB) dye loaded- and grafted- PNPs, respectively. The latter were produced by blending into the PLGA–PEG matrix a RhB-labeled polyaspartamide/polylactide graft copolymer to ensure a stable fluorescence during the time of analysis. Photon correlation spectroscopy (PCS), UV-visible (UV-vis) spectroscopies, differential scanning calorimetry (DSC), atomic force microscopy (AFM) were used to characterize the RhB-loaded and RhB-grafted PNPs. To assess their potential use for brain targeting, cytotoxicity tests were carried out on olfactory ensheathing cells (OECs) and neuron-like differentiated PC12 cells. Both PNP types showed mean sizes suitable for nose-to-brain delivery (<200 nm, PDI < 0.3) and were not cytotoxic toward OECs in the concentration range tested, while a reduction in the viability on PC12 cells was found when higher concentrations of nanomedicines were used. Both the RhB-labelled NPs are suitable drug carrier models for exploring cellular trafficking in nose-to-brain delivery for short-time or long-term studies.
format Online
Article
Text
id pubmed-8471208
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-84712082021-09-27 mPEG-PLGA Nanoparticles Labelled with Loaded or Conjugated Rhodamine-B for Potential Nose-to-Brain Delivery Craparo, Emanuela Fabiola Musumeci, Teresa Bonaccorso, Angela Pellitteri, Rosalia Romeo, Alessia Naletova, Irina Cucci, Lorena Maria Cavallaro, Gennara Satriano, Cristina Pharmaceutics Article Nowdays, neurodegenerative diseases represent a great challenge from both the therapeutic and diagnostic points of view. Indeed, several physiological barriers of the body, including the blood brain barrier (BBB), nasal, dermal, and intestinal barriers, interpose between the development of new drugs and their effective administration to reach the target organ or target cells at therapeutic concentrations. Currently, the nose-to-brain delivery with nanoformulations specifically designed for intranasal administration is a strategy widely investigated with the goal to reach the brain while bypassing the BBB. To produce nanosystems suitable to study both in vitro and/or in vivo cells trafficking for potential nose-to-brain delivery route, we prepared and characterized two types of fluorescent poly(ethylene glycol)-methyl-ether-block-poly(lactide-co-glycolide) (PLGA–PEG) nanoparticles (PNPs), i.e., Rhodamine B (RhB) dye loaded- and grafted- PNPs, respectively. The latter were produced by blending into the PLGA–PEG matrix a RhB-labeled polyaspartamide/polylactide graft copolymer to ensure a stable fluorescence during the time of analysis. Photon correlation spectroscopy (PCS), UV-visible (UV-vis) spectroscopies, differential scanning calorimetry (DSC), atomic force microscopy (AFM) were used to characterize the RhB-loaded and RhB-grafted PNPs. To assess their potential use for brain targeting, cytotoxicity tests were carried out on olfactory ensheathing cells (OECs) and neuron-like differentiated PC12 cells. Both PNP types showed mean sizes suitable for nose-to-brain delivery (<200 nm, PDI < 0.3) and were not cytotoxic toward OECs in the concentration range tested, while a reduction in the viability on PC12 cells was found when higher concentrations of nanomedicines were used. Both the RhB-labelled NPs are suitable drug carrier models for exploring cellular trafficking in nose-to-brain delivery for short-time or long-term studies. MDPI 2021-09-18 /pmc/articles/PMC8471208/ /pubmed/34575584 http://dx.doi.org/10.3390/pharmaceutics13091508 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Craparo, Emanuela Fabiola
Musumeci, Teresa
Bonaccorso, Angela
Pellitteri, Rosalia
Romeo, Alessia
Naletova, Irina
Cucci, Lorena Maria
Cavallaro, Gennara
Satriano, Cristina
mPEG-PLGA Nanoparticles Labelled with Loaded or Conjugated Rhodamine-B for Potential Nose-to-Brain Delivery
title mPEG-PLGA Nanoparticles Labelled with Loaded or Conjugated Rhodamine-B for Potential Nose-to-Brain Delivery
title_full mPEG-PLGA Nanoparticles Labelled with Loaded or Conjugated Rhodamine-B for Potential Nose-to-Brain Delivery
title_fullStr mPEG-PLGA Nanoparticles Labelled with Loaded or Conjugated Rhodamine-B for Potential Nose-to-Brain Delivery
title_full_unstemmed mPEG-PLGA Nanoparticles Labelled with Loaded or Conjugated Rhodamine-B for Potential Nose-to-Brain Delivery
title_short mPEG-PLGA Nanoparticles Labelled with Loaded or Conjugated Rhodamine-B for Potential Nose-to-Brain Delivery
title_sort mpeg-plga nanoparticles labelled with loaded or conjugated rhodamine-b for potential nose-to-brain delivery
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8471208/
https://www.ncbi.nlm.nih.gov/pubmed/34575584
http://dx.doi.org/10.3390/pharmaceutics13091508
work_keys_str_mv AT craparoemanuelafabiola mpegplgananoparticleslabelledwithloadedorconjugatedrhodaminebforpotentialnosetobraindelivery
AT musumeciteresa mpegplgananoparticleslabelledwithloadedorconjugatedrhodaminebforpotentialnosetobraindelivery
AT bonaccorsoangela mpegplgananoparticleslabelledwithloadedorconjugatedrhodaminebforpotentialnosetobraindelivery
AT pellitterirosalia mpegplgananoparticleslabelledwithloadedorconjugatedrhodaminebforpotentialnosetobraindelivery
AT romeoalessia mpegplgananoparticleslabelledwithloadedorconjugatedrhodaminebforpotentialnosetobraindelivery
AT naletovairina mpegplgananoparticleslabelledwithloadedorconjugatedrhodaminebforpotentialnosetobraindelivery
AT cuccilorenamaria mpegplgananoparticleslabelledwithloadedorconjugatedrhodaminebforpotentialnosetobraindelivery
AT cavallarogennara mpegplgananoparticleslabelledwithloadedorconjugatedrhodaminebforpotentialnosetobraindelivery
AT satrianocristina mpegplgananoparticleslabelledwithloadedorconjugatedrhodaminebforpotentialnosetobraindelivery